AIDITE 2025 Annual Report: Revenue of 1.035 Billion Yuan, Overseas Market Revenue of 686 Million Yuan

Source: AIDITE 2025 Annual Report

DentalGoodNews｜On April 29, 2026, Aidite (Qinhuangdao) Technology Co., Ltd. (hereinafter referred to as "Aidite") released its 2025 annual report and 2026 first quarter report. The report shows that the company achieved operating revenue of RMB 1.035 billion in 2025, a year-on-year increase of 16.51%; net profit attributable to shareholders of the parent company was RMB 196 million, up 30.39% year-on-year; net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was RMB 173 million, up 17.65% year-on-year. Net cash flow from operating activities was RMB 274 million, up 82.32% year-on-year.

Source: AIDITE 2026 First Quarter Report

In the first quarter of 2026, the growth trend continued, with operating revenue reaching RMB 257 million, a year-on-year increase of 25.35%; net profit attributable to shareholders of the parent company was RMB 38.26 million, up 22.33% year-on-year; net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was RMB 34.52 million, up 27.40% year-on-year. Net cash flow from operating activities in the first quarter was RMB 6.5175 million, down 70.73% year-on-year, mainly due to increased procurement expenditures driven by expanded revenue scale and timing differences in tax refunds, rather than a deterioration in operational quality; financial expenses rose to RMB 9.22 million due to exchange losses (compared to a gain of RMB 3.9 million in the same period last year), caused by the appreciation of the RMB against the backdrop of a continuously increasing proportion of overseas revenue.

Source: AIDITE 2025 Annual Report

In terms of product structure, in 2025, the company's dental restoration materials achieved revenue of RMB 736 million, up 13.97% year-on-year, contributing 71.16% of total revenue, with a gross margin of 60.65%. The digital equipment business for oral applications achieved revenue of RMB 222 million, up 20.50% year-on-year, primarily driven by increased demand for dental lab cutting equipment and clinical chairside restoration systems under the digital transformation trend. [①P22]

In overseas markets during the reporting period, Aidite achieved overseas revenue of RMB 686 million, up 24.90% year-on-year, with its share of total revenue rising from 61.85% in the previous year to 66.31%. The company stated that by establishing subsidiaries and conducting local operations in mature markets such as the United States, Germany, South Korea, and Japan, it has enhanced overseas brand awareness and customer collaboration stickiness.

Source: AIDITE 2025 Annual Report

In terms of R&D investment, Aidite's R&D expenditure in 2025 reached RMB 73.5862 million, up 55.37% year-on-year, with R&D investment as a percentage of revenue rising from 5.33% to 7.11%. In the first quarter of 2026, R&D expenses reached RMB 20.41 million, up 59.45% year-on-year. As of the end of 2025, the company had 187 R&D personnel, accounting for 20.26% of total employees, forming a core R&D team led by multiple doctoral and master's degree holders. During 2025, the company newly obtained 9 NMPA, FDA, CE, and other domestic and international medical device registration certificates; the company and its subsidiaries held a total of 167 valid patents.

In terms of industry-academia-research collaboration, the company stated that it has established cooperative relationships with institutions such as Peking University School of Stomatology and West China Hospital of Stomatology, Sichuan University. Under the "Open Competition Mechanism" of the Ministry of Science and Technology's "14th Five-Year Plan" National Key R&D Program, it successfully developed a series of resin-infiltrated ceramic block materials with antibacterial functions; the joint laboratory established with Peking University School of Stomatology has also achieved phased progress, completing the digital setup of major diagnostic and treatment workflows in digital solutions, providing relevant technical foundations and verification pathways for the digital transformation of industry participants such as dental laboratories.

According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), Aidite announced in April that it plans to invest RMB 100 million to establish an industrial fund, specifically investing in the leading orthodontic consumables company Pute Medical, aiming to fill gaps in its orthodontic pipeline and build three pillar businesses: restoration, dental implant, and orthodontics. Previously, the company completed the acquisition of South Korea's Warantec dental implant company, further improving its digital implantology solutions.

In terms of infrastructure construction, Aidite stated that its dental industrial park project is progressing as planned. The park will include facilities for the industrialization of oral CAD/CAM materials, a digital oral comprehensive service platform, and a R&D pilot base. Upon completion, it will achieve a closed loop of R&D, pilot production, mass production, and recycling, and add multiple automated production lines. Additionally, the company is focusing on developing a SaaS system for the digital oral comprehensive service platform, aiming to bridge the collaboration loop between doctors and dental lab technicians.

Furthermore, according to Aidite's disclosure, based on 107 million shares, the company plans to distribute a cash dividend of RMB 4.6 (including tax) for every 10 shares to all shareholders, and to issue 4 additional shares for every 10 shares held through capital reserve capitalization.